The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2019 | CLL genomics: p53 mutations and deletions
Riccardo Bomben
• 22 Sep 2019
Riccardo Bomben, PhD, CRO Centre of Oncological Reference of Aviano, Aviano, Italy, discusses p53 mutations in chronic lymphocytic leukemia (CLL) and analyses current sequencing methods. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.
